Pharmaceutical Practices And Patient Outcomes
54 researchers across 8 institutions
Research in pharmaceutical practices and patient outcomes examines how medications are used in clinical settings and the subsequent effects on individuals and populations. This area encompasses studies on medication safety, medication therapy management, drug adherence, and the development of evidence-based guidelines for medication use. Methodologies include clinical trials, observational studies, retrospective data analysis, and qualitative research exploring patient experiences and provider perspectives. Investigations often focus on specific disease states, vulnerable patient populations, and the impact of pharmacy services on health outcomes and healthcare costs.
This research is particularly relevant to Arkansas, a state with significant rural populations and specific health challenges. Studies address medication access and adherence in underserved communities, the impact of pharmacy interventions on chronic disease management prevalent in the state, and the effective use of pharmaceuticals within the context of Arkansas's healthcare system. Understanding these factors is crucial for improving public health and health equity across the state.
This field draws upon and contributes to healthcare policy, medical education, public health, and health sciences research. Engagement spans multiple institutions across Arkansas, fostering a broad base of expertise and collaborative potential within the state's higher education and research landscape.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Peter A. Crooks | UAMS | 57 | 14,934 | ARA High Impact | |
| Christopher Johnson | UAMS | 50 | 14,110 | ||
| Aleda M.H. Chen | UAMS | 27 | 2,449 | High Impact | |
| Cindy D. Stowe | UAMS | 22 | 2,234 | High Impact | |
| Megan G. Smith | UAMS | 11 | 485 | ||
| Denise Ragland | UAMS | 10 | 404 | ||
| Laura E. Gressler | UAMS | 9 | 406 | ||
| Jill Johnson | UAMS | 9 | 207 | ||
| Nikhil Singh | University of Arkansas – Fort Smith | 7 | 375 | ||
| Rachel Stafford | UAMS | 6 | 140 | ||
| P. Murphy | UAMS | 5 | 116 | ||
| Amy D. Robertson | University of Arkansas | 5 | 101 | ||
| Efrata Ashuro Shegena | UAMS | 4 | 52 | ||
| Kaci Boehmer | UAMS | 4 | 44 | ||
| Weida Tong | NCTR | 4 | 681 | ARA | |
| Angie N. Choi | UAMS | 4 | 67 | ||
| Kaci Thiessen | UAMS | 4 | 31 | ||
| Maya Wai | University of Arkansas | 3 | 147 | ||
| Lois Coulter | UAMS | 3 | 36 | ||
| Jim Washam | Arkansas State University | 3 | 103 |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 University of North Carolina at Chapel Hill 1,277
- 2 Harvard University 1,125
- 3 University of Michigan 915
- 4 Brigham and Women's Hospital 901
- 5 Johns Hopkins University 880
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Pharmaceutical Practices And Patient Outcomes.